Influence of obesity and gastric bypass on medication absorption: pharmacokinetic study
- Conditions
- Obese volunteers and volunteers with a Roux-en-Y gastric bypass (RYGB)
- Registration Number
- EUCTR2012-001244-22-BE
- Lead Sponsor
- KU Leuven - Centre for Pharmacotherapy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- obese volunteers who will undergo a RYGB and volunteers who underwent a RYGB > 6 months
- minimum age: 18 years
- for Microgynon: women between 18 and 45 years
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 135
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- patients with major postoperative gastrointestinal complications (e.g. anastomic leak or outlet obstruction)
- pregnancy
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method